NCT06511401View on ClinicalTrials.gov

Informing Pain Treatment Using Pharmacogenomic Analysis

NARecruitingINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

July 30, 2024

Primary Completion Date

January 7, 2028

Study Completion Date

March 31, 2028

Conditions
Adult Patients Who Are Receiving Oncologic Care
Interventions
OTHER

Pharmacogenomic (PGx) results.

These results are designed to provide specific dosing information based on the participant's unique genetics/genomics.

Trial Locations (1)

60637

RECRUITING

University of Chicago Medicine Comprehensive Cancer Center, Chicago

All Listed Sponsors
collaborator

National Human Genome Research Institute (NHGRI)

NIH

lead

University of Chicago

OTHER